Literature DB >> 21575665

Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.

Michelle F Clarke1, Geoffrey P Davidson, Michael S Gold, Helen S Marshall.   

Abstract

Rotavirus vaccine for infants was introduced into the National Immunisation Program in Australia in July 2007. To determine the impact of rotavirus vaccination on gastroenteritis hospitalisations amongst children less than six years of age in South Australia, we conducted a retrospective analysis of hospital admissions over two time periods: 1 May 2005-30 April 2007 (prior to rotavirus vaccination introduction) and 1 May 2008-30 April 2010 (post rotavirus vaccination introduction). The introduction of rotavirus vaccination has been associated with a marked reduction in hospital admissions for serious rotavirus gastroenteritis (RVGE) and all-cause gastroenteritis (ACGE). Following the introduction of rotavirus vaccination in South Australia, there was an 83% reduction in RVGE coded admissions (955 vs 165) and a 48% reduction in ACGE coded admissions (4153 vs 2142) for children aged less than six years. Children less than two years demonstrated the greatest reduction (90%) in RVGE admissions and ACGE admissions (57%). Age-specific RVGE hospitalisation rates decreased from 933/100,000 prior to rotavirus vaccine introduction to 88/100,000 for children less than two years of age. In addition, for gastroenteritis hospitalisations for children aged five years at time of admission (unvaccinated cohort) there was a reduction in the number of RVGE cases (24 vs 4), a reduction in age-specific RVGE hospitalisation rates (65/100,000 vs 11/100,000) and a significant reduction in the proportion of overall gastroenteritis cases which were rotavirus positive (11.5% vs 3.5%), suggesting a positive impact on both unvaccinated and vaccinated children less than six years of age in South Australia.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21575665     DOI: 10.1016/j.vaccine.2011.04.109

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  New insights into rotavirus vaccines.

Authors:  Chiara Mameli; Valentina Fabiano; Gian Vincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

Review 2.  Rotavirus vaccines: current status and future considerations.

Authors:  Catherine Yen; Jacqueline E Tate; Terri B Hyde; Margaret M Cortese; Benjamin A Lopman; Baoming Jiang; Roger I Glass; Umesh D Parashar
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

3.  Rotavirus vaccines: current global impact and future perspectives.

Authors:  Eleanor Burnett; Catherine Yen; Jacqueline E Tate; Umesh D Parashar
Journal:  Future Virol       Date:  2016-10       Impact factor: 1.831

4.  Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.

Authors:  V L Rahajamanana; J L Raboba; A Rakotozanany; N J Razafindraibe; E J P R Andriatahirintsoa; A C Razafindrakoto; S A Mioramalala; C Razaiarimanga; G G Weldegebriel; E Burnett; J M Mwenda; M Seheri; M J Mphahlele; A L Robinson
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

5.  Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany.

Authors:  Sandra Dudareva-Vizule; Judith Koch; Matthias An der Heiden; Doris Oberle; Brigitte Keller-Stanislawski; Ole Wichmann
Journal:  Hum Vaccin Immunother       Date:  2012-09-07       Impact factor: 3.452

6.  Infection status and circulating strains of rotaviruses in Chinese children younger than 5-years old from 2011 to 2018: systematic review and meta-analysis.

Authors:  Jingxin Li; Hong Wang; Dandi Li; Qing Zhang; Na Liu
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

7.  Rotavirus Disease and Genotype Diversity in Older Children and Adults in Australia.

Authors:  Celeste M Donato; Susie Roczo-Farkas; Carl D Kirkwood; Graeme L Barnes; Julie E Bines
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

8.  Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis.

Authors:  Parveen Fathima; Mark A Jones; Hannah C Moore; Christopher C Blyth; Robyn A Gibbs; Thomas L Snelling
Journal:  J Epidemiol       Date:  2020-10-30       Impact factor: 3.211

9.  Measuring indirect effects of rotavirus vaccine in low income countries.

Authors:  Aisleen Bennett; Naor Bar-Zeev; Nigel A Cunliffe
Journal:  Vaccine       Date:  2016-07-18       Impact factor: 3.641

10.  Characterisation of a G2P[4] Rotavirus Outbreak in Western Australia, Predominantly Impacting Aboriginal Children.

Authors:  Celeste M Donato; Nevada Pingault; Elena Demosthenous; Susie Roczo-Farkas; Julie E Bines
Journal:  Pathogens       Date:  2021-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.